As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scaliaasked CEO David Ricks if the company ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...

What Happened: Ricks's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday, involves purchasing 2,250 shares of Adobe. The total transaction value is ...

That’s how much Eli Lilly’s revenue grew in 2024, but it was still not as much as the company or investors expected, which had CEO David Ricks trying to assuage investors. Lilly on Tuesday ...

our previous guidance had anticipated even faster acceleration of growth for the quarter,” said Lilly CEO David Ricks, referring to demand for the company’s medications that mimic the effects ...

Eli Lilly forecasts $45 billion in 2024 revenue, a 32% growth but $400 million below Q3 guidance. Mounjaro and Zepbound expected to contribute $3.5 billion and $1.9 billion, respectively, to 2024 ...

It was revealed in a recent SEC filing that David Ricks, Board Member at Adobe (NASDAQ:ADBE) made a noteworthy insider purchase on January 31,. What Happened: Ricks's recent move, as outlined in a ...

Eli Lilly CEO David Ricks, also an Adobe director, paid $1 million on Jan. 28 for 2,250 shares of the software company.